<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Halfdanarson TR</submitter><funding>NIDDK NIH HHS</funding><funding>NIAID NIH HHS</funding><pagination>1042-7</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3594736</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8(12)</volume><pubmed_abstract>&lt;h4>Background &amp; aims&lt;/h4>Celiac disease (CD) is associated with an increased risk of lymphoma. However, relatively few studies have assessed the outcome of patients diagnosed with both CD and lymphoma. We evaluated the temporal association between lymphoma and CD, along with clinical presentation, response to therapy, and prognosis.&lt;h4>Methods&lt;/h4>Patients diagnosed with both CD and lymphoma were identified retrospectively in a tertiary referral center. Clinical characteristics and survival were analyzed.&lt;h4>Results&lt;/h4>Sixty-three patients (36 men) were identified who had been diagnosed with lymphoma and CD. Thirty-six (57%) were diagnosed with CD before they were diagnosed with lymphoma. The most common histologic entity was diffuse, large, B-cell lymphoma, which affected 18 (29%) patie</pubmed_abstract><journal>Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association</journal><pubmed_title>Patients with celiac disease and B-cell lymphoma have a better prognosis than those with T-cell lymphoma.</pubmed_title><pmcid>PMC3594736</pmcid><funding_grant_id>R01 DK057892</funding_grant_id><funding_grant_id>T32 AI007047</funding_grant_id><funding_grant_id>DK-57892</funding_grant_id><funding_grant_id>T32 AI-07047</funding_grant_id><pubmed_authors>Habermann TM</pubmed_authors><pubmed_authors>Rubio-Tapia A</pubmed_authors><pubmed_authors>Halfdanarson TR</pubmed_authors><pubmed_authors>Ristow KM</pubmed_authors><pubmed_authors>Murray JA</pubmed_authors><pubmed_authors>Inwards DJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Patients with celiac disease and B-cell lymphoma have a better prognosis than those with T-cell lymphoma.</name><description>&lt;h4>Background &amp; aims&lt;/h4>Celiac disease (CD) is associated with an increased risk of lymphoma. However, relatively few studies have assessed the outcome of patients diagnosed with both CD and lymphoma. We evaluated the temporal association between lymphoma and CD, along with clinical presentation, response to therapy, and prognosis.&lt;h4>Methods&lt;/h4>Patients diagnosed with both CD and lymphoma were identified retrospectively in a tertiary referral center. Clinical characteristics and survival were analyzed.&lt;h4>Results&lt;/h4>Sixty-three patients (36 men) were identified who had been diagnosed with lymphoma and CD. Thirty-six (57%) were diagnosed with CD before they were diagnosed with lymphoma. The most common histologic entity was diffuse, large, B-cell lymphoma, which affected 18 (29%) patie</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 Dec</publication><modification>2025-04-19T09:55:51.301Z</modification><creation>2019-03-26T23:06:36Z</creation></dates><accession>S-EPMC3594736</accession><cross_references><pubmed>20851210</pubmed><doi>10.1016/j.cgh.2010.09.007</doi></cross_references></HashMap>